Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Raphaela Goldbach‐Mansky(National Institutes of Health), Daniel L. Kastner(National Institutes of Health), Natalie Dailey Garnes(National Institutes of Health), Scott Penzak(National Institutes of Health Clinical Center), Ivona Aksentijevich(National Institutes of Health), Robert W. Warren(Baylor College of Medicine), John A. Butman(National Institutes of Health Clinical Center), Bracha Shaham(Children's Hospital of Los Angeles), Philip N. Hawkins(The Royal Free Hospital), Robert Wesley(National Institutes of Health Clinical Center), Janet H. Jones(National Institutes of Health), William Horn(Watauga Medical Center), Scott M. Paul(National Institutes of Health Clinical Center), Margje H. Haverkamp(National Institutes of Health), H. Jeffrey Kim(National Institute on Deafness and Other Communication Disorders), Laurie Beitz(Seattle Children's Hospital), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Richard K. Vehe(University of Minnesota System), Frank Pucino(National Institutes of Health Clinical Center), Edythe Wiggs(National Institutes of Health), Christopher Zalewski(National Institute on Deafness and Other Communication Disorders), Robert C. Fuhlbrigge(Boston Children's Museum), Barbara I. Karp(National Institute of Neurological Disorders and Stroke), William P. Hannan(State University of New York), Scott Canna(Children's Hospital of Philadelphia), Joe L. Cole(Adult and Pediatric Dermatology), A Gelabert(National Institutes of Health), Gregory C. Gardner(University of Washington), James N. Jarvis(University of Washington), Suvimol Hill(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Benjamin I. Rubin(National Institutes of Health), Kathleen M. O’Neil(Oklahoma City University), Terry L. Moore(St. Luke's Hospital), Barbara S. Adams(University of Michigan), Steven C. Hoffmann(National Institutes of Health), Leonard D. Stein(University of North Carolina at Chapel Hill), Tuyet Pham(National Institutes of Health), Christopher S. Snyder(National Institutes of Health), Maria L. Turner(National Institutes of Health), Carmen C. Brewer(National Institute on Deafness and Other Communication Disorders)
Cited by 902
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k